In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.
about
The role of epigenetics in the pathology of diabetic complicationsEpigenetics: a molecular link between environmental factors and type 2 diabetesHistone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyHistone acetyltransferases: challenges in targeting bi-substrate enzymesEpigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutritionNutrition, epigenetics, and metabolic syndromeThe emerging role of epigenetics in cardiovascular diseaseHuman genetics of diabetic vascular complicationsDiabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 DiabetesThe "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic ComplicationsMapping global histone methylation patterns in the coding regions of human genesHistone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic isletsThe histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivoThe influence of early life nutrition on epigenetic regulatory mechanisms of the immune system.Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes.Enhancement of inflammatory protein expression and nuclear factor Κb (NF-Κb) activity by trichostatin A (TSA) in OP9 preadipocytesNovel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylationEpigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.Epigenetic mechanisms in diabetic vascular complications.Epigenetics: deciphering its role in diabetes and its chronic complications.Epigenetic mechanisms in diabetic complications and metabolic memory.Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model.Eicosanoids, β-cell function, and diabetesCCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathwaysGenome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradationHistone H3 phosphorylation (Ser10, Ser28) and phosphoacetylation (K9S10) are differentially associated with gene expression in liver of rats treated in vivo with acute ethanolHeritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expressionProfiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes.Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.A role for epigenetic changes in the development of retinal neurodegenerative conditions.Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in HyperglycemiaMetabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.
P2860
Q24609124-2A04CA81-1221-4230-8F65-173CC7409C57Q24652830-646DF2C6-93FB-4F41-9924-87C7A83E10B2Q26744442-38E2E950-9D90-464C-9B8D-E1FAE4E84AD8Q26745642-B9710846-EA24-4C09-84B4-2F73F5FB5C8AQ26822513-34D6089C-108A-45DF-B901-1C534DB478DCQ26829684-FED71442-0DA1-415E-ADFF-683720347AD9Q26852614-D9B2186C-73D8-45AD-8248-FD9BDBB0555DQ27000709-CF071330-4FF0-4C83-8F99-483838FDAE3CQ28072462-74352E99-7493-481A-9B6C-8B325A4B55ECQ28079163-6DADC583-D7AD-43A9-A03E-B77C353770D9Q28579534-A2525A66-ECBE-4BC5-A5A0-ED8A3202801FQ30300141-9260E772-F46F-4714-97CB-430125A93782Q33749208-C8487290-CD2E-4BFC-8A20-1AC8FAAD70ADQ33837026-2D8A1BD8-BC18-4808-B46C-6B4C8ACF00B4Q33893161-5C4852EB-1B16-4C92-92AB-28947A940CC2Q34023548-41615AC5-446B-42EE-87DE-91A986713648Q34472678-8B66303F-9060-4821-AA7C-7FCD74A71B74Q34504770-4B15DCCC-8812-4B7F-A4B2-07304E71D52EQ34577954-AB892273-CEFF-42FB-9D3C-BF5E50691291Q34597924-150CFBBE-6415-4A9B-B613-69FA3ACE408AQ34651949-29377E8B-EE6D-4703-8AD5-5EAF0460A50BQ34666690-DD9295E6-12C0-4F92-B85C-D3BD4C2F894AQ34780528-059E1CB9-F3EE-475E-91D8-DDAF87E7DAF1Q34986508-9C912ECF-6F8D-4E2C-BA8E-C8D1CA701202Q35068854-55A49D75-045F-4767-94C0-993B74658097Q35071700-01205555-72FB-4DA9-9380-666459520691Q35112822-EB04221D-6C70-4CF3-B595-E31ACD1B2604Q35129888-88A79DB8-D150-44BB-9201-073052B7C58BQ35238090-312365DE-A145-4835-AA33-577AB827C31EQ35451716-20426E6D-28BE-4C99-B2E9-19C88B9D14D3Q35645997-B83F2C9F-15EA-4266-8D65-CC3A12AFBC7CQ35652362-8A686562-D521-4F25-A755-D6571D367452Q35660728-560AD264-E3B9-4108-A37E-0A1836AAFF37Q35688536-73748802-1807-42FB-BD80-49F597603922Q35696490-47519AA1-D74E-48FB-848F-4A112AC59371Q35956543-391137AE-D4BF-476E-9462-8D4AAC86F40AQ35976043-5E1A7CE6-F72C-410C-8E36-4E1B13A7745CQ36055920-F58343FE-B868-4D66-8238-40A8BFDD0F23Q36129769-2C83BFAA-C9C3-4F32-9619-FEA1AB21CD31Q36205231-D01118EF-6516-4001-A89F-30013639CC6F
P2860
In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@ast
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@en
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@nl
type
label
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@ast
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@en
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@nl
prefLabel
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@ast
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@en
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@nl
P2093
P2860
P356
P1476
In vivo chromatin remodeling e ...... ion under diabetic conditions.
@en
P2093
Irene Gaw Gonzalo
Linda Lanting
Rama Natarajan
P2860
P304
18091-18097
P356
10.1074/JBC.M311786200
P407
P577
2004-02-19T00:00:00Z